Showing 1-10 of 58 grants

Title Institution Researcher Program Duration Total Award Amount
Localized Immunosuppressive Antibody Therapy for Enhancing Islet Graft Survival in Type 1 Diabetes Aeterna Therapeutics Maria Kondratyev Cures 01-May-2026 to 28-February-2027 $200.000,00
Deciphering the logic of genetic variant interactions in autoimmunity Arc Insitute Maya Arce Cures 01-September-2026 to 31-August-2027 $148.614,38
GLUT1 Inhibition in type 1 diabetes Beckman Research Institute of the City of Hope Alberto Pugliese Cures 01-November-2022 to 31-July-2026 $494.072,25
Combination therapy with STX4 activating small molecules or small activating RNA together with harmine to stimulate beta-cell regeneration and enhance functional beta-cell mass Beckman Research Institute of the City of Hope Debbie Thurmond Cures 01-October-2025 to 30-September-2028 $1.050.000,00
Modulation of beta cell mRNA Translation in Type 1 Diabetes Beckman Research Institute of the City of Hope Farooq Syed Cures 01-September-2024 to 31-March-2027 $444.138,25
Pilot Clinical Trial of Allogenic Islet Transplantation under the Abdominal Anterior Rectus Sheath for Advancing Treatment of Type 1 Diabetes Beckman Research Institute of the City of Hope Fouad Kandeel Cures 01-October-2026 to 30-September-2028 $800.000,00
Novel Cell-free DNA and RNA Dynamics in Islet Transplant Beckman Research Institute of the City of Hope Fouad Kandeel Cures 01-August-2026 to 31-July-2028 $600.000,00
Non-invasive immunoimaging of islet transplant rejection Beckman Research Institute of the City of Hope Fouad Kandeel Cures 01-June-2023 to 31-May-2027 $750.000,00
Do Islet Somatic Mutations Contribute to T1D Age at Onset? Beckman Research Institute of the City of Hope Melanie Shapiro Cures 01-March-2026 to 28-February-2027 $100.000,00
Clinical Trial of Denosumab for Type 1 Diabetes Beckman Research Institute of the City of Hope Rupangi Vasavada Cures 01-October-2023 to 30-November-2027 $2.232.400,00